Closing the osteoporosis management gap in primary care: a secondary prevention of fracture programme

References

• World Health Organization. Assessment of fracture risk and its application to screening for post menopausal osteoporosis. Technical report series 843. Geneva: World Health Organization, 1994
   Google Scholar
• Scottish Intercollegiate Guidelines Network. Management of osteoporosis 71. Edinburgh, June 2003. Available from http://www.sign.ac.uk/pdf/sign71.pdf [Accessed 6 Aug 2004]
   Google Scholar
• Melton LJ 3rd, Chrischilles EA, Cooper C, Lane AW, Riggs BL. Perspective. How many women have osteoporosis? J Bone Miner Res 1992;7:1005–10
   PubMed Web of Science ®Google Scholar
• International Osteoporosis Foundation. Bone-health neglected by European women despite awareness of osteoporosis, new pan-European health survey shows. Nice, France, June 5, 2004. Available from http://www.osteofound.org/press_centre/%20pr_2004_06_04.html [Accessed 6 Aug 2004]
   Google Scholar
• Klotzbuecher C, Ross P, Landsman P, Abbott T, Berger M. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 2000;15:721–39
   Google Scholar
• Elliot-Gibson V Bogoch ER, Jamal SA, Beaton DE. Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 2004;15:767–78
   PubMedGoogle Scholar
• Amamra N, Berr C, Clavel-Chapelon F, Delcourt C, Delmas PD, Derriennic F, Ducimetiere P Goldberg M, Letenneur L, Rabilloud M, Meunier P-J, Schot A-M. Estimated number of women likely to benefit from bone mineral density measurement in France. Joint Bone Spine 2004;71:409–18
   Google Scholar
• Eisman J, Clapham S, Kehoe L. Osteoporosis prevalence and levels of treatment in primary care: the Australian Bone Care Study. J Bone Miner Res 2004;19:1969–1975 [Epub 13 Sep 2004]
   Google Scholar
• O'Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ. The prevalence of vertebral deformity in European man and women: The European Vertebral Osteoporosis Study. J Bone Miner Res 1996;11:1010–8
   PubMed Web of Science ®Google Scholar
• Kanis JA, Glüer C-C. An update on the diagnosis and assessment of osteoporosis with densitometry. Osteoporos Int 2000;11:192–202
   PubMed Web of Science ®Google Scholar
• Burge RT, Worley D, Johansen A, et al. The cost of osteoporotic fractures in the UK: projections for 2000–2020. J Med Economics 2001;4:51–62; data extrapolated from: Johansen A, Evans RJ, Stone MD, Richmond PW Lo SV Woodhouse KW Fracture incidence in England and Wales: a study based on the population of Cardiff. Injury 1997;28: 655–60
   Google Scholar
• Office of National Statistics. Mid-2000 population estimates. HMSO, 2001
   Google Scholar
• Robinson CM, Royds M, Abraham A, McQueen MM, CourtBrown CM, Christie J. Refracture in patients at least 45 years old. A retrospective analysis of twenty-two thousand and sixty patients. J Bone Joint Surg 2002;84A:1528–33
   Google Scholar
• Woolf AD, Åkesson K. Preventing fractures in elderly people. BMJ 2003;327:89–95
   PubMed Web of Science ®Google Scholar
• European Commission. Report on osteoporosis in the European Community – Action for prevention. Luxembourg: Office for Official Publications of the European Communities, 1998. Available from http://www.osteofound.org/publications/pdf/eu_report_98.pdf [Accessed 6 Aug 2004]
   Google Scholar
• Province MA, Hadley EC, Hornbrook MC, Lipsitz LA, Miller JP, Mulrow CD, Ory MG, Sattin RW, Tinetti ME, Wolf SL. The effects of exercise on falls in elderly patients. A preplanned metaanalysis of the FICSIT Trials. Frailty and Injuries: Cooperative Studies of Intervention Techniques. JAMA 1995;273:1341–7
   Google Scholar
• Cranney A, Guyatt G, Griffith L, Wells G, Tugwell P Rosen C. Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group. Meta-analysis of therapies for post-menopausal osteoporosis. IX: Summary of meta-analysis of therapies for postmenopausal osteoporosis. Endocr Rev 2002;23:570–8
   Google Scholar
• Scottish Forum for Public Health Medicine. Scottish needs assessment programme. Osteoporosis. Glasgow, 1997. Available from http://www.phis.org.uk/Doc.pl?file%20=%20publications/Osteoporosis%20report.Doc [Accessed 9 Aug 2004]
   Google Scholar
• Cryer C, Patel S. Falls, fragility and fractures. National Service Framework for Older People: The case for and strategies to implement a joint health improvement and modernisation plan for falls and osteoporosis. November 2003. Available from http://www.kent.ac.uk/chss/publications/fallsfragility&fractures. pdf [Accessed 6 Aug 2004]
   Google Scholar
• Kanis JA, Johnell O, Oden A, De Laet C, Jonsson B, Dawson A. Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies. Bone 2002;30:251–8
   Google Scholar
• Royal College of Physicians. Osteoporosis: clinical guidelines for prevention and treatment. London: Royal College of Physicians, 1999
   Google Scholar
• Royal College of Physicians and Bone and Tooth Society. Osteoporosis: clinical guidelines for prevention and treatment. Update on pharmacological interventions and an algorithm for management. London: Royal College of Physicians, 2000
   Google Scholar
• NHS Lanarkshire, Department of Rheumatology. Guidelines for the investigation and management of osteoporosis. NHS Lanarkshire, Department of Rheumatology. May 2004
   Google Scholar
• National Institute for Clinical Excellence. Bisphosphonates (alendronate, etidronate, risedronate), selective oestrogen receptor modulators (raloxifene) and parathyroid hormone (teriparatide) for the secondary prevention of osteoporotic fragility fractures in postmenopausal women. 2004. Available from http://www.nice.org.uk/pdf/FAD_osteoporosis_secondary.%20pdf [Accessed 9 Aug 2004]
   Google Scholar
• Miller PD, Siris ES, Barrett-Connor E, Faulkner KG, Wehren LE, Abbott TA, Chen Y-T, Berger ML, Santora AC, Sherwood LM. Prediction of Fracture Risk in Postmenopausal White Women With Peripheral Bone Densitometry: Evidence From the National Osteoporosis Risk Assessment. J Bone Min Res 2002;17:2222–30
   Google Scholar
• British Orthopaedic Association Blue Book. The care of fragility fracture patients. London: September 2003. Available from http://www.boa.ac.uk/PDF%20files/care%20of20%fragility%20f ractures.pdf [Accessed 9 Aug 2004]
   Google Scholar
• National Osteoporosis Society. Osteoporosis and fracture prevention strategy for Wales. June 2003
   Google Scholar
• Torgerson DJ, Dolan P. Prescribing by general practitioners after an osteoporotic fracture. Ann Rheum Dis 1998;57:378–9
   PubMed Web of Science ®Google Scholar
• Pal B. Questionnaire survey of advice given to patients with fractures. Br Med J 1999;318:500–1
   PubMed Web of Science ®Google Scholar
• Kanterewicz E, Yanez A. Osteoporosis attitudes after a Colles fracture. Arch Intern Med 2001;161:2633–4
   PubMed Web of Science ®Google Scholar
• Hajcar EE, Hawker G, Bogoch ER. Investigation and treatment of osteoporosis in patients with fragility fractures. Can Med Assoc J 2000;163:819–22
   Google Scholar
• Andrade SE, Majumdar SR, Chan KA, Buist DS, Go AS, Goodman M, Smith DH, Platt R, Gurwitz JH. Low frequency of treatment of osteoporosis among post-menopausal women following a fracture. Arch Intern Med 2003;163:2052–7
   Google Scholar
• Liel Y, Castel H, Bonneh DY. Impact of subsidising effective antiosteoporosis drugs on compliance with management guidelines in patients following low-impact fractures. Osteoporosis Int 2003;14:490–5
   Google Scholar
• Simonelli C, Chen YT, Morancey J, Lewis AF, Abbott TA. Evaluation and management of osteoporosis following hospitalisation for low-impact fracture. J Gen Intern Med 2003;18:17–22
   Google Scholar
• Wong PKK, Spenser DG, McElduff P Manolios N, Larcos G, Howe GB. Secondary screening for osteoporosis in patients admitted with minimal-trauma fracture to a major teaching hospital. Int Med J 2003;33:505–10
   Google Scholar
• Penneman MJM, Lips P Sen SS, Herings RM. Undertreatment with anti-osteoporotic drugs after hospitalisation for fracture. Osteoporosis Int 2004;15:120–4
   PubMed Web of Science ®Google Scholar
• Sueta CA, Chowdhury M, Boccuzzi SJ, Smith Jr SC, Alexander CM, Londhe A, Lulla A, Simpson Jr RJ. Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease. Am J Cardiol 1999;83:1303–7
   Google Scholar
• Fonarow GC, Gawlinski A, Moughrabi S, Tillisch JH. Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP). Am J Cardiol 2001;87:819–22
   PubMed Web of Science ®Google Scholar
• Lappe JM, Muhlestein JB, Lappe DL, Badger RS, Bair TL, Brockman R, French TK, Hofmann LC, Horne BD, Kralick- Goldberg S, Nicponski N, Orton JA, Pearson RR, Renlund DG, Rimmasch H, Roberts C, Anderson JL. Improvements in 1-year cardiovascular clinical outcomes associated with a hospital-based discharge medication program. Ann Intern Med 2004;141: 446–53
   Google Scholar
• McLellan AR, Gallacher SJ, Fraser M, McQuillian C. The fracture liaison service: success of a program for the evaluation and management of patients with osteoporotic fracture. Osteoporos Int 2003;14:1028–34
   PubMed Web of Science ®Google Scholar